OCA real world experience

OCA real world experience

OCA real world experience

Since OCA (Ocaliva) was approved in the US in 2016 and Canada in 2017, there have been several  studies to assess its effectiveness in PBC patients around the world.  Here are some links to those studies.

Hirschfield, Hansen: OCA improves AST-to-platelet ratio index and GLOBE score in PBC

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724188/

Italian real-world experience with OCA

https://pubmed.ncbi.nlm.nih.gov/33681748/

Iberian real-world experience with OCA

https://pubmed.ncbi.nlm.nih.gov/33314220/

Canadian (CaNAL) real-world experience with OCA (July 2020)

https://pubmed.ncbi.nlm.nih.gov/32923836/